One year results of intravitreal ranibizumab monotherapy for retinal angiomatous proliferation: a comparative analysis based on disease stages

Overview of attention for article published in BMC Ophthalmology, December 2015

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (54th percentile)
Good Attention Score compared to outputs of the same age and source (79th percentile)

So far, Altmetric has seen 5 X posts from 5 X users, with an upper bound of 25,713 followers.

[VEGF] One year results of intravitreal ranibizumab monotherapy for retinal angiomatous proliferation: a c... https://t.co/3N8xk9iqAk PM

One year results of intravitreal ranibizumab monotherapy for retinal angiomatous proliferation: a comparative anal… https://t.co/lnfkh0A3AS

Three doses of intravitreal ranibizumab is effective for early stage Retinal angiomatous proliferation https://t.co/GPd8TfszN4

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.